FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
-0.48%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$172M
AUM Growth
+$2.72M
(+1.6%)
Cap. Flow
+$9.68M
Cap. Flow
% of AUM
5.61%
Top 10 Holdings %
Top 10 Hldgs %
73.91%
Holding
46
New
5
Increased
12
Reduced
13
Closed
6
Top Buys
| 1 |
Transportadora de Gas del Sur
TGS
|
+$5.38M |
| 2 |
Petrobras Class A
PBR.A
|
+$5.17M |
| 3 |
EDN
Edenor
EDN
|
+$3.21M |
| 4 |
Mercado Libre
MELI
|
+$2.94M |
| 5 |
Telecom Argentina
TEO
|
+$2.81M |
Top Sells
| 1 |
VEON
VEON
|
+$4.38M |
| 2 |
Ambev
ABEV
|
+$2.02M |
| 3 |
Pampa Energía
PAM
|
+$1.38M |
| 4 |
TAL Education Group
TAL
|
+$761K |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$572K |
Sector Composition
| 1 | Financials | 31.86% |
| 2 | Communication Services | 20.43% |
| 3 | Consumer Discretionary | 14.08% |
| 4 | Consumer Staples | 11.7% |
| 5 | Energy | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$137B
| $274K | 0.16% |
8,923
-3,960
| -31% | -$122K |
|
27
Penumbra
PEN
$10B
| $268K | 0.16% |
4,230
| – | – |
|
28
Bristol-Myers Squibb
BMY
$93.9B
| $253K | 0.15% |
4,347
| – | – |
|
29
Ultrapar
UGP
$4.22B
| $249K | 0.14% |
24,096
+296
| +1% | +$3.06K |
|
30
Amgen
AMGN
$148B
| $238K | 0.14% |
1,633
| – | – |
|
|
CELG
31
DELISTED
Celgene Corp
CELG
| $234K | 0.14% |
2,026
| – | – |
|
32
Eli Lilly
LLY
$681B
| $230K | 0.13% |
+3,135
| New | +$230K |
|
33
Neurocrine Biosciences
NBIX
$14.2B
| $215K | 0.12% |
5,584
| – | – |
|
34
BRF SA
BRFS
$6.7B
| $174K | 0.1% |
11,839
-837
| -7% | -$12.3K |
|
|
AKRX
35
DELISTED
Akorn, Inc.
AKRX
| $169K | 0.1% |
7,763
| – | – |
|
36
Arrowhead Research
ARWR
$4.03B
| $159K | 0.09% |
+102,815
| New | +$159K |
|
37
Vale
VALE
$46.4B
| $159K | 0.09% |
20,841
-2,951
| -12% | -$22.5K |
|
|
LCI
38
DELISTED
Lannett Company, Inc.
LCI
| $138K | 0.08% |
1,581
| – | – |
|
|
AMRN
39
Amarin Corp
AMRN
$302M
| $116K | 0.07% |
+1,894
| New | +$116K |
|
40
Telefônica Brasil
VIV
$20.4B
| $104K | 0.06% |
7,788
-1,938
| -20% | -$25.9K |
|
41
DexCom
DXCM
$30B
| – | – |
-24,692
| Closed | -$543K |
|
42
Abbott
ABT
$233B
| – | – |
-5,711
| Closed | -$242K |
|
43
Edwards Lifesciences
EW
$44.1B
| – | – |
-8,262
| Closed | -$333K |
|
44
Thermo Fisher Scientific
TMO
$178B
| – | – |
-2,020
| Closed | -$322K |
|
45
Waters Corp
WAT
$18.1B
| – | – |
-1,771
| Closed | -$282K |
|
|
ABMD
46
DELISTED
Abiomed Inc
ABMD
| – | – |
-4,437
| Closed | -$572K |
|